Increasing the surface area when plasma and water interact could help scale up a technology that destroys contaminants such ...
Catherine, born with Down syndrome and Tetralogy of Fallot (TOF), a rare congenital heart condition, has regained her quality of life after undergoing a novel Venus P™ valve implantation at the ...
The vascular system, integral to organismal homeostasis, is composed of numerous organ-specific subsystems that, while ...
Year, and Adjusted EBITDA of $11.7 Million, up 34% Year-Over YearNine Month Revenue of $135.8 Million, up 11% Year-over-Year; ...
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the 2025 Transcatheter Cardiovascular Therapeutics (TCT) ...
Marius Pharmaceuticals, Inc. a patient-centric healthcare company committed to advancing innovative therapies for testosterone deficiency, today announced that Health Canada has approved KYZATREX® ...
The global patient monitoring devices market size is expected to reach USD 118.21 billion by 2033, registering a CAGR of 10.21% from 2025 to 2033, according to a new report by Grand View Research, Inc ...
A wearable for depression? Our honest review of the NHS-backed Flow Neuroscience Headset - Offering a proven, non-invasive ...
Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...